top of page

The Labor Department Finalized the PBM Fee Disclosure Rule. Here Is What Plan Fiduciaries Should Do Next

Nov 2
5 min read

On October 29, 2026, the Department of Labor released its final rule on pharmacy benefit manager fee disclosure for large self-insured health plans. As of our October briefing, the rule had not yet arrived. It is out now, and the Federal Register published it on November 2, 2026 (91 Fed. Reg. 69092). This post covers what the Department says the rule does, the dates that matter, what is still open, and what a plan committee can do before the first disclosures come due.

What the final rule requires

The rule carries the Department's identifier RIN 1210-AB37 and amends 29 CFR Part 2550. It works through ERISA Section 408(b)(2), the provision that governs reasonable arrangements with service providers. It covers providers of pharmacy benefit management services and affiliated providers of brokerage and consulting services. They must disclose their compensation to the responsible fiduciaries of large self-insured group health plans, so those fiduciaries can decide whether the arrangement is reasonable. The Department also says the rule includes provisions designed to let fiduciaries verify that the disclosures are accurate.

The Department describes covered plans by size, following ERISA Section 726: an employer that averaged at least 100 employees on business days during the preceding calendar year, or a plan that averaged at least 100 participants during the preceding plan year.

The Department's preamble describes disclosures of the services provided, any fiduciary status, and direct and indirect compensation, including how it is allocated among providers, affiliates, and subcontractors. It also refers to spread compensation and drug pricing methodology, and it describes the rebate-related terms as tracking ERISA Section 726. Initial disclosures come at contracting, extension, or renewal. Later disclosures come every six months, or quarterly if the plan asks.

This summary rests on the Department's summary and preamble. The itemized disclosure list and the definitions are in the rule's codified text, which counsel should read in full.

The dates that matter

According to the DATES section of the Federal Register version (91 Fed. Reg. 69092, November 2, 2026), the rule is effective January 4, 2027 and applies to plan years beginning on or after July 1, 2027. For a calendar-year plan, the first plan year the rule reaches is the one that begins on January 1, 2028.

A separate set of requirements comes from the Consolidated Appropriations Act, 2026 (CAA 2026). Its new ERISA Section 408(b)(2)(C), which requires providers to remit 100% of rebates, fees, alternative discounts, and other remuneration, and its ERISA Section 726 reporting apply to plan years beginning on or after August 3, 2028. The two sets of requirements overlap in subject matter but not in timing, so track them on separate calendars. Our litigation and regulatory tracker lists both.

What we do not know yet

Several points are still open. Only the Federal Register version is official, and we have not reviewed the codified text of the verification provisions, whose scope matters. Press coverage reports the Department's projections of $22 billion in lower drug costs over ten years and first-year PBM compliance costs of about $1 million. Those are agency projections, not realized figures. The Pharmaceutical Care Management Association called the rule "a solution in search of a problem." We had seen no legal challenge as of October 29.

What a committee can do now

The rule does not take effect for months, but contracts you sign this winter may still be in force when the first disclosures come due. A prudent process starts with the contracts and the record.

1. List every arrangement in which a PBM, broker, or consultant is paid by or through the plan, and note whether any of them are affiliated with each other.

2. Ask each provider in writing how and when it will deliver the disclosures the rule describes, and in what format.

3. At the next renewal, add disclosure timing, a verification right, and a remittance provision to the PBM and consulting contracts. The PBM conflict checklist is a useful starting point for the questions to ask.

4. Name the committee member who will review the first disclosures, and decide how the review will be recorded in the minutes.

5. Have counsel read the Federal Register version, because that version controls.

The record matters because, as our Comprehensive Fiduciary Requirements Guide puts it, "ERISA fiduciary liability centers on whether the decision-making PROCESS was prudent, not whether the OUTCOME was optimal." For the enforcement backdrop, see our CAA 2026 enforcement guide.

Where does your plan stand?

ClaimInformatics™ offers a complimentary ASO agreement and SPD analysis to find hidden fiduciary risks in your self-funded plan contracts before renewal. Request a complimentary ASO analysis, or email hello@claiminformatics.com.

Related resources

FAQs Block

Who does the final PBM fee disclosure rule apply to?

The Department says it requires providers of pharmacy benefit management services, and affiliated providers of brokerage and consulting services, to disclose their compensation to the responsible fiduciaries of large self-insured group health plans. Following ERISA Section 726, the Department describes large as an employer averaging at least 100 employees or a plan averaging at least 100 participants.

When does the rule apply?

It is effective January 4, 2027 and applies to plan years beginning on or after July 1, 2027. The Department released it on October 29, 2026, and the Federal Register published it on November 2, 2026 (91 Fed. Reg. 69092).

What must be disclosed, and how often?

The Department's preamble describes compensation disclosures that include direct and indirect compensation, spread compensation, and drug pricing methodology, with rebate-related terms that track ERISA Section 726. Initial disclosures come at contracting, extension, or renewal, followed by disclosures every six months, or quarterly if the plan asks. Counsel should confirm the itemized list in the codified text.

Is this the same as the CAA 2026 PBM provisions?

No. The Consolidated Appropriations Act, 2026 added ERISA Section 408(b)(2)(C) and Section 726, which apply to plan years beginning on or after August 3, 2028. The final rule is a separate Department of Labor regulation with its own July 1, 2027 applicability date.

What should a plan committee do first?

List the PBM, broker, and consulting arrangements that touch the plan, ask each provider in writing how it will deliver the disclosures, and plan to add disclosure and verification terms at the next renewal. Counsel should read the Federal Register version.

This content is provided for fiduciary decision-making purposes. It does not constitute legal advice. Plan fiduciaries should consult with qualified ERISA counsel before taking action on any recommendations.

Comments


bottom of page